kisplyx 10 mg capsule
eisai pharma ag - lenvatinibum - capsule - lenvatinibum 10 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, kapselhülle: hypromellosum, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula. - behandlung von fortgeschrittenem nierenzellkarzinom (rcc) - synthetika
p3-rete presagomata alta densita'
dipro medical devices s.r.l. - reti in polipropilene
p3-rete presagomata bassa densita'
dipro medical devices s.r.l. - reti in polipropilene
p3-rete presagomata bassa densita'
dipro medical devices s.r.l. - reti in polipropilene
p3-rete presagomata bassa densita'
dipro medical devices s.r.l. - reti in polipropilene
p3-rete presagomata bassa densita'
dipro medical devices s.r.l. - reti in polipropilene
p3-rete presagomata bassa densita'
dipro medical devices s.r.l. - reti in polipropilene
p3-rete presagomata bassa densita'
dipro medical devices s.r.l. - reti in polipropilene
p3-rete presagomata bassa densita'
dipro medical devices s.r.l. - reti in polipropilene
p3-rete presagomata bassa densita'
dipro medical devices s.r.l. - reti in polipropilene